Hepatic mesenchymal hamartoma

J-B Yen1, M-S Kong, J-N Lin

  • 1Department of Pediatrics of Chang Gung Memorial Hospital, Chiayi, Chang Gung Children's Hospital, Taoyuan, Taiwan, Republic of China.

Insights

Hepatic mesenchymal hamartoma (HMH) is a rare childhood liver tumor. Surgical excision offers a good prognosis, with no recurrence observed in surviving patients in this study.

Area of Science:

  • Pediatric Oncology
  • Hepatobiliary Surgery

Background:

  • Hepatic mesenchymal hamartoma (HMH) is a rare, typically benign liver tumor in children.
  • Complete surgical excision is considered curative, with rare instances of recurrence or metastasis.

Observation:

  • This retrospective review analyzed 134 patients with liver lesions, identifying four cases of HMH.
  • Common presentations included abdominal mass and distension, with three cases diagnosed within the first year of life.
  • Liver function tests and tumor markers were found to be non-specific for HMH diagnosis.

Findings:

  • Three of the four pediatric HMH cases underwent complete tumor excision, while one had tumor enucleation.
  • One patient experienced a fatal outcome, but no tumor recurrence was noted in the remaining three surviving patients.

Implications:

  • Surgical management, particularly complete excision, appears effective for pediatric hepatic mesenchymal hamartoma.
  • Early diagnosis and surgical intervention are crucial for favorable outcomes in HMH cases.
  • Further research into the specific factors influencing HMH behavior and prognosis is warranted.

Related Concept Videos